Holly Edmonds, MD
Dermatology · Atlanta, GANPI 1326244831
Payments from drug & device makers
Across 482 payments — averaging $20.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$832
- Johnson & Johnson$829
- Sun Pharmaceutical Industries Inc.$697
- Galderma Laboratories, L.p.$532
- plus $4K from 29 others
What the payments were for
- Food & beverage$9,88799%
- Education$971%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 107 | $1,874 |
| Sanofi | 28 | $1,037 |
| Regeneron Healthcare Solutions, Inc. | 32 | $832 |
| Johnson & Johnson | 43 | $829 |
| Sun Pharmaceutical Industries Inc. | 32 | $697 |
| Galderma Laboratories, L.p. | 32 | $532 |
| LEO Pharma Inc. | 23 | $436 |
| Amgen | 17 | $384 |
| E.r. Squibb & Sons, L.L.C. | 15 | $374 |
| Incyte Corporation | 16 | $365 |
| Lilly USA, LLC | 17 | $353 |
| Arcutis Biotherapeutics, Inc. | 9 | $314 |
| Almirall LLC | 13 | $273 |
| Pfizer | 13 | $251 |
| Mayne Pharma Commercial LLC | 22 | $245 |
| Novartis | 10 | $199 |
| Dermavant Sciences, Inc. | 12 | $184 |
| VYNE Pharmaceuticals Inc. | 6 | $143 |
| Sandoz | 5 | $88 |
| UCB, Inc. | 4 | $78 |
| Bristol Myers Squibb | 3 | $69 |
| Verrica Pharmaceuticals Inc. | 3 | $56 |
| Botanix SB Inc | 3 | $56 |
| Organon | 3 | $45 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $38 |
| Nabriva Therapeutics, PLC | 2 | $36 |
| EPI Health, LLC | 2 | $34 |
| Dermira, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Journey Medical Corporation | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZORYVE$137
How this compares
$9,984 in reported general payments places this provider in the 75th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 48 | $2,714 |
| Ketoconazole | 69 | $1,565 |
| Metronidazole | 17 | $813 |
| Triamcinolone Acetonide | 54 | $712 |
| ValacyclovirValacyclovir Hcl | 41 | $498 |
| Clindamycin Phosphate | 13 | $462 |
| Mupirocin | 58 | $428 |
| Nystatin | 24 | $364 |
| Cephalexin | 15 | $315 |
| Doxycycline Hyclate | 16 | $274 |
| Hydrocortisone | 33 | $174 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Atlanta
- Jamie WeismanAtlanta$4.9M
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$722K
- Ron FeldmanAtlanta$483K
- Jack ArbiserAtlanta$453K
- Mack RachalAtlanta$316K
- Tunisia CorneliusAtlanta$210K
- Emily AltmanAtlanta$178K
- Hailey RouhanaAtlanta$157K
- Lauren OrensteinAtlanta$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.